DJIA 16,833.52 57.09 0.34%
NASDAQ 4,750.88 -30.38 -0.64%
S&P 500 1,985.18 -1.87 -0.09%
market minute promo

3.87 -0.38 (-8.94%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

THLD $3.87 -8.94%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.22
Previous Close $4.25
Daily Range $3.92 - $4.22
52-Week Range $2.58 - $5.28
Market Cap $276.1M
P/E Ratio -8.17
Dividend (Yield) $0.00 (0.0%)
Volume 218,709
Average Daily Volume 852,969
Current FY EPS -$0.51




Drug Makers


A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer. Website:

News & Commentary Rss Feed

According to Wall Street, These Small-Cap Biotech Stocks Could Triple

All three of these small-cap biotech stocks could return 200% (or more) for their shareholders if Wall Street's price targets are accurate.

Threshold Pharmaceuticals (THLD) Is Weak On High Volume Today

Stocks Hitting 52-Week Highs

Strong On High Volume: Threshold Pharmaceuticals (THLD)

Threshold Pharma, ATOMIC Initiate First Phase 2 Trial of TH-4000 in Patients with Advanced EGFR-Muta

Threshold Pharma, ATOMIC Initiate First Phase 2 Trial of TH-4000 in Patients with Advanced EGFR-Mutant, T790M-NSCLC

2 Biotech Stocks That Could Skyrocket In The Next 12 Months

3 Top Biotech Stocks for High-Risk Investors

Can your stomach handle the risk associated with these potentially high-flying biotech growth stocks?

Threshold Pharmaceuticals: Hard Road Toward Success

3 Biotech Stocks 50% (or More) Off Their 5-Year Highs That Could Double

Wall Street has cast these three biotech stocks to the proverbial scrap heap over the past five years, but a big rebound may soon be in order.

Cantor Still Expects Threshold Pharma To More Than Triple, Says 2016 Will Be 'Data Rich' Year

See More THLD News...

THLD's Top Competitors

THLD $3.87 (-8.94%)
Current stock: THLD
AMGN $139.58 (-2.93%)
Current stock: AMGN
GILD $96.49 (-2.79%)
Current stock: GILD
BIIB $271.90 (-5.11%)
Current stock: BIIB